Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mind Medicine (MindMed) Inc.

7.79
+0.10001.30%
Post-market: 7.910.1200+1.54%19:58 EDT
Volume:1.10M
Turnover:8.65M
Market Cap:588.56M
PE:-7.36
High:8.01
Open:7.88
Low:7.72
Close:7.69
Loading ...

Mind Medicine (MindMed) Inc. Files Initial Beneficial Ownership Statement for CFO Brandi Roberts

Reuters
·
03 Jun

Mind Medicine (MNMD) Initiated with a Buy at Oppenheimer

TIPRANKS
·
02 Jun

Mind Medicine (MNMD) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
29 May

MindMed Inc. to Present at Jefferies Global Healthcare Conference

Reuters
·
28 May

Mind Medicine Names Brandi Roberts CFO

MT Newswires Live
·
27 May

MindMed Appoints Brandi Roberts as Chief Financial Officer to Strengthen Executive Team

Reuters
·
27 May

MindMed Strengthens Executive Team With Appointment of Brandi Roberts, Cpa, as Chief Financial Officer

THOMSON REUTERS
·
27 May

MindMed Announces Inducement Grants for New Employees with Four-Year Vesting Plan

Reuters
·
20 May

MindMed to Present at RBC Capital Markets Global Healthcare Conference in New York

Reuters
·
13 May

Mind Medicine Is Maintained at Buy by Chardan Capital

Dow Jones
·
09 May

Mind Medicine (MindMed) Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Mind Medicine Q1 EPS $(0.35) Beats $(0.38) Estimate

Benzinga
·
08 May

BRIEF-MindMed Q1 Net Income USD -23.348 Million

Reuters
·
08 May

H.C. Wainwright Sticks to Their Buy Rating for Mind Medicine (MNMD)

TIPRANKS
·
01 May

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr

Press Release: MindMed to Report First Quarter 2025 Financial Results on May 8, 2025

Dow Jones
·
24 Apr

Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)

Simply Wall St.
·
23 Apr

BRIEF-Mind Medicine (Mindmed) Inc - Mindmed Enters Into First Amendment To Loan And Security Agreement - SEC Filing

Reuters
·
22 Apr

Mind Medicine (MindMed) Inc - MindMed Enters Into First Amendment to Loan and Security Agreement - SEC Filing

THOMSON REUTERS
·
22 Apr

Mind Medicine Doses First Patient in Phase 3 Trial on MM120 for Major Depressive Disorder

MT Newswires Live
·
15 Apr